O. Kutsevalova, A. Antonets, V. Krylov, N. Nifantiev, D. Miroshnichenko, A. Mikutin
{"title":"COVID-19相关的侵袭性真菌病","authors":"O. Kutsevalova, A. Antonets, V. Krylov, N. Nifantiev, D. Miroshnichenko, A. Mikutin","doi":"10.14427/jipai.2021.4.49","DOIUrl":null,"url":null,"abstract":"The COVID-19 pandemic has revealed the new forms of invasive fungal infections. Without timely diagnosis and treatment, mortality reaches 100%. We analyzed 31 observed cases of invasive mucormycosis and aspergillosis in patients with COVID-19 to identify risk factors, the time sequence of the onset of clinical symptoms, and diagnostic features. Major predisposing factors were diabetes mellitus, immunosuppressive therapy, and oncological diseases.","PeriodicalId":425120,"journal":{"name":"Immunopathology, Allergology, Infectology","volume":"19 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"COVID-19 associated invasive mycoses\",\"authors\":\"O. Kutsevalova, A. Antonets, V. Krylov, N. Nifantiev, D. Miroshnichenko, A. Mikutin\",\"doi\":\"10.14427/jipai.2021.4.49\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The COVID-19 pandemic has revealed the new forms of invasive fungal infections. Without timely diagnosis and treatment, mortality reaches 100%. We analyzed 31 observed cases of invasive mucormycosis and aspergillosis in patients with COVID-19 to identify risk factors, the time sequence of the onset of clinical symptoms, and diagnostic features. Major predisposing factors were diabetes mellitus, immunosuppressive therapy, and oncological diseases.\",\"PeriodicalId\":425120,\"journal\":{\"name\":\"Immunopathology, Allergology, Infectology\",\"volume\":\"19 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Immunopathology, Allergology, Infectology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14427/jipai.2021.4.49\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunopathology, Allergology, Infectology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14427/jipai.2021.4.49","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The COVID-19 pandemic has revealed the new forms of invasive fungal infections. Without timely diagnosis and treatment, mortality reaches 100%. We analyzed 31 observed cases of invasive mucormycosis and aspergillosis in patients with COVID-19 to identify risk factors, the time sequence of the onset of clinical symptoms, and diagnostic features. Major predisposing factors were diabetes mellitus, immunosuppressive therapy, and oncological diseases.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
